Rapid Influenza Diagnostic Test Market

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
Rapid Influenza Diagnostic Test Market aims to provide a comprehensive presentation of the global market for Rapid Influenza Diagnostic Test (RIDT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Influenza Diagnostic Test (RIDT). Rapid Influenza Diagnostic Test Market contains market size and forecasts of Rapid Influenza Diagnostic Test (RIDT) in global, including the following market information:
Global Rapid Influenza Diagnostic Test (RIDT) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Rapid Influenza Diagnostic Test (RIDT) market was valued at US$ 1305.8 million in 2022 and is projected to reach US$ 2328.4 million by 2029, at a CAGR of 8.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Americas is the largest Rapid Influenza Diagnostic Test (RIDT) market with about 58% market share. Europe is follower, accounting for about 25% market share.
The key players are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy etc. Top 3 companies occupied about 49% market share.
We surveyed the Rapid Influenza Diagnostic Test (RIDT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rapid Influenza Diagnostic Test (RIDT) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Rapid Influenza Diagnostic Test (RIDT) Market Segment Percentages, by Type, 2022 (%)
Digital RIDTs
Conventional RIDT
Global Rapid Influenza Diagnostic Test (RIDT) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Rapid Influenza Diagnostic Test (RIDT) Market Segment Percentages, by Application, 2022 (%)
Hospitals
POCT
Others
Global Rapid Influenza Diagnostic Test (RIDT) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Rapid Influenza Diagnostic Test (RIDT) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rapid Influenza Diagnostic Test (RIDT) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Rapid Influenza Diagnostic Test (RIDT) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rapid Influenza Diagnostic Test (RIDT), market overview.
Chapter 2: Global Rapid Influenza Diagnostic Test (RIDT) market size in revenue.
Chapter 3: Detailed analysis of Rapid Influenza Diagnostic Test (RIDT) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rapid Influenza Diagnostic Test (RIDT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.